Relay Therapeutics Inc RLAY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
22.07UNCH (UNCH)
Volume
33,475
Close
22.07quote price arrow down-0.69 (-3.03%)
Volume
687,792
52 week range
12.65 - 35.36
Loading...
  • Open22.61
  • Day High22.95
  • Day Low22.00
  • Prev Close22.76
  • 52 Week High35.36
  • 52 Week High Date04/04/22
  • 52 Week Low12.65
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap2.668B
  • Shares Out120.89M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change47.72

KEY STATS

  • Open22.61
  • Day High22.95
  • Day Low22.00
  • Prev Close22.76
  • 52 Week High35.36
  • 52 Week High Date04/04/22
  • 52 Week Low12.65
  • 52 Week Low Date06/14/22
  • Market Cap2.668B
  • Shares Out120.89M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change47.72

RATIOS/PROFITABILITY

  • EPS (TTM)-2.70
  • P/E (TTM)-8.19
  • Fwd P/E (NTM)-7.25
  • EBITDA (TTM)-290.149M
  • ROE (TTM)-36.98%
  • Revenue (TTM)1.695M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-17,136.40%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Relay Therapeutics Inc

 

Profile

MORE
Relay Therapeutics Inc. is a clinical-stage precision medicines company. The Company is focused on transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company is advancing a pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008, RLY-2608 and RLY-1971. Its RLY-1971 binds and stabilizes Src homology region two (SH2)-containing protein...
Alexis Borisy
Independent Chairman of the Board
Sanjiv Patel M.D.
President, Chief Executive Officer, Director
Thomas Catinazzo
Chief Financial Officer
Charles Ferte
Vice President, Global Medical Lead
Address
399 Binney Street, 2Nd Floor
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
SAGE
SAGE Therapeutics Inc
44.16-0.43-0.96%
ISEE
IVERIC bio Inc
23.24-0.75-3.13%
PRTA
Prothena Corporation PLC
57.75+2.20+3.96%
PCVX
Vaxcyte Inc
45.25-0.25-0.55%
AMLX
Amylyx Pharmaceuticals Inc
36.64-0.36-0.97%